Acadia Pharmaceuticals Inc (ACAD)

Feb 21, 2025

Director Commercial Launch Excellence and PlanningAcadia Pharmaceuticals Inc. - Built In

Feb 21, 2025

Feb 21, 2025

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 21, 2025

Feb 20, 2025

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Sold by Rice Hall James & Associates LLC - MarketBeat

Feb 20, 2025

Feb 20, 2025

ACADIA Pharmaceuticals (ACAD) to Release Quarterly Earnings on Tuesday - MarketBeat

Feb 20, 2025

Feb 19, 2025

Drug developers struggle in 2024; Fibrogen, Acadia, Atai post gains - BioWorld Online

Feb 19, 2025

Feb 19, 2025

JP Morgan Week 2025 – Catherine Owen Adams - pharmaphorum

Feb 19, 2025

Feb 18, 2025

ACADIA Pharmaceuticals Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily

Feb 18, 2025

Feb 18, 2025

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Short Interest Down 5.2% in January - MarketBeat

Feb 18, 2025

Feb 17, 2025

Acadia Pharmaceuticals Turns Heads with Ambitious Stock Awards - mivalle.net.ar

Feb 17, 2025

Feb 17, 2025

Biotech Giant Acadia Pharmaceuticals Lures Talent with Slick New Stock Incentives - Jomfruland.net

Feb 17, 2025

Feb 17, 2025

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 14, 2025 - BioSpace

Feb 17, 2025

Feb 14, 2025

ACADIA Pharmaceuticals (NASDAQ:ACAD) Now Covered by Analysts at Deutsche Bank Aktiengesellschaft - MarketBeat

Feb 14, 2025

Feb 13, 2025

Is the Options Market Predicting a Spike in ACADIA Pharmaceuticals (ACAD) Stock? - MSN

Feb 13, 2025

Feb 13, 2025

Acadia Pharmaceuticals: Good Progress Means I'm Reversing My 'Sell' Call To 'Buy' - Seeking Alpha

Feb 13, 2025

Feb 12, 2025

Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Business Wire

Feb 12, 2025

Feb 12, 2025

10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

Feb 12, 2025

Feb 12, 2025

Deutsche Bank Initiates Coverage of ACADIA Pharmaceuticals (ACAD) with Hold Recommendation - MSN

Feb 12, 2025

Feb 12, 2025

Acadia's Q4 Results Coming: Major Updates on Breakthrough Parkinson's and Rett Syndrome Treatments - StockTitan

Feb 12, 2025

Feb 11, 2025

Deutsche Bank sets Acadia Pharmaceuticals stock target at $22 By Investing.com - Investing.com Nigeria

Feb 11, 2025

Feb 11, 2025

Deutsche Bank sets Acadia Pharmaceuticals stock target at $22 - MSN

Feb 11, 2025

Feb 11, 2025

Deutsche Bank Initiates Coverage on ACADIA Pharmaceuticals With Hold Rating, $22 Price Target - Marketscreener.com

Feb 11, 2025

Feb 11, 2025

Neuroregeneration Therapy Market to Surpass USD 64.8 Billion by 2034, Driven by Advancements in Regenerative Medicine and Rising Neurological Disorders | Transparency Market Research - GlobeNewswire Inc.

Feb 11, 2025

Feb 07, 2025

BlackRock, Inc. Increases Stake in ACADIA Pharmaceuticals Inc. - GuruFocus.com

Feb 07, 2025

Feb 06, 2025

High Growth Tech Stocks To Watch In February 2025 - Simply Wall St

Feb 06, 2025

Feb 06, 2025

Schizophrenia Market Expected to rise, 2034 | Boehringer - openPR

Feb 06, 2025

Feb 04, 2025

Leerink Partnrs Brokers Increase Earnings Estimates for ACAD - MarketBeat

Feb 04, 2025

Feb 03, 2025

Leerink Partnrs Has Optimistic Outlook of ACAD Q4 Earnings - MarketBeat

Feb 03, 2025

Feb 01, 2025

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Short Interest Update - Defense World

Feb 01, 2025

Jan 31, 2025

Q4 EPS Estimate for ACADIA Pharmaceuticals Raised by Analyst - Defense World

Jan 31, 2025

Jan 31, 2025

DCGI nod to Bajaj Healthcare for manufacturing Parkinson's disease psychosis drug Pimavanserin in India - Medical Dialogues

Jan 31, 2025

Jan 29, 2025

ACADIA Pharmaceuticals' SWOT analysis: stock outlook amid mixed product performance - MSN

Jan 29, 2025

Jan 29, 2025

3 Hidden Bargains in the Healthcare Sector - Inkl

Jan 29, 2025

Jan 29, 2025

VTRS: 3 Hidden Bargains in the Healthcare Sector - StockNews.com

Jan 29, 2025

Jan 28, 2025

How Biopharma Leaders Are Leveling Up Sales Strategies For 2025 - FiercePharma

Jan 28, 2025

Jan 27, 2025

Acadia’s New CEO Outlines Growth Strategy - News & Insights

Jan 27, 2025

Jan 27, 2025

Brokerages Set ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Target Price at $25.25 - MarketBeat

Jan 27, 2025

Jan 26, 2025

Acadia (ACAD) Q4 Earnings Lag, Sales Beat Estimates, Stock Down - MSN

Jan 26, 2025

Jan 24, 2025

ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Up 6.4%Still a Buy? - MarketBeat

Jan 24, 2025

Jan 24, 2025

Research Analysts Offer Predictions for ACAD FY2025 Earnings - Defense World

Jan 24, 2025

Jan 24, 2025

Brokers Issue Forecasts for ACAD FY2025 Earnings - MarketBeat

Jan 24, 2025

Jan 23, 2025

SG Americas Securities LLC Increases Stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - MarketBeat

Jan 23, 2025

Jan 22, 2025

ACADIA Pharmaceuticals (ACAD) Stock Price, News & Analysis - MarketBeat

Jan 22, 2025

Jan 18, 2025

ACAD Seeks EU Nod for Rett Syndrome Drug, Outlines 2025 Pipeline Goals - MSN

Jan 18, 2025

Jan 17, 2025

ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Down 6.9%Time to Sell? - MarketBeat

Jan 17, 2025

Jan 17, 2025

JPM25: After taking the wheel at Acadia, CEO Catherine Owen Adams looks to steer firm toward $1B in sales - FiercePharma

Jan 17, 2025